Literature DB >> 17554483

Results of visual acuity and foveal thickness in diabetic macular edema after vitrectomy.

Yuka Shimonagano1, Reiko Makiuchi, Miho Miyazaki, Norihito Doi, Akinori Uemura, Taiji Sakamoto.   

Abstract

PURPOSE: To report results of an investigation of visual acuity (VA) and foveal thickness in diabetic macular edema (DME) patients after vitrectomy.
METHODS: A retrospective study was performed of the records of 47 patients (61 eyes) who received pars plana vitrectomy (PPV) for DME. All eyes were followed up for over 6 months (mean, 24.8 months; range, 6-60 months). VA and foveal thickness evaluated by optical coherence tomography were reviewed preoperatively and postoperatively.
RESULTS: Twenty-four-month follow-up data were available for 46 of the 61 eyes (75%). VA at the final examination had improved by 0.2 log units or more in 34 of the 61 eyes (56%), remained unchanged in 21 eyes (34%), and worsened in six eyes (10%). Mean foveal thickness decreased by more than 20% of the preoperative value in 50 of the 61 eyes (82%), remained unchanged in ten eyes (16%), and increased by more than 20% in one eye (2%) at the final examination. Postoperative best-corrected visual acuity (BCVA) at both 12 and 24 months was significantly better than preoperative BCVA (P < 0.0001). Foveal thickness at 3 months or later significantly decreased from the preoperative value (P < 0.0001), but remained unchanged in comparison with postoperative 12 months and 24 months values (P = 0.19). Preoperative VA and presence of cystoid macular edema (CME) were independently associated with final visual acuity (P = 0.001).
CONCLUSIONS: PPV for DME effectively improved VA and reduced foveal thickness for a longer postoperative period. Better preoperative VA was associated with better final postoperative VA. The eyes without CME tended to have better final postoperative VA. Copyright (c) Japanese Ophthalmological Society 2007.

Entities:  

Mesh:

Year:  2007        PMID: 17554483     DOI: 10.1007/s10384-007-0423-8

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  24 in total

1.  Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid.

Authors:  T Ikeda; K Sato; T Katano; Y Hayashi
Journal:  Retina       Date:  2000       Impact factor: 4.256

2.  Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid.

Authors:  S D Pendergast; T S Hassan; G A Williams; M S Cox; R R Margherio; P J Ferrone; B R Garretson; M T Trese
Journal:  Am J Ophthalmol       Date:  2000-08       Impact factor: 5.258

3.  Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.

Authors:  Pascale Massin; Graham Duguid; Ali Erginay; Belkacem Haouchine; Alain Gaudric
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

4.  A controlled study of vitrectomy for diabetic macular edema.

Authors:  Tomohiro Otani; Shoji Kishi
Journal:  Am J Ophthalmol       Date:  2002-08       Impact factor: 5.258

5.  Pars plana vitrectomy in diabetic macular edema.

Authors:  T Micelli Ferrari; N Cardascia; G Durante; M Vetrugno; L Cardia
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

6.  Relation of diabetic macular edema to cytokines and posterior vitreous detachment.

Authors:  Hideharu Funatsu; Hidetoshi Yamashita; Tomohiro Ikeda; Tatsuya Mimura; Erika Shimizu; Sadao Hori
Journal:  Am J Ophthalmol       Date:  2003-03       Impact factor: 5.258

7.  Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.

Authors:  Hideharu Funatsu; Hidetoshi Yamashita; Tomohiro Ikeda; Tatsuya Mimura; Shuichiro Eguchi; Sadao Hori
Journal:  Ophthalmology       Date:  2003-09       Impact factor: 12.079

8.  Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.

Authors:  Jost B Jonas; Robert F Degenring; Bernd A Kamppeter; Ingrid Kreissig; Imren Akkoyun
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

9.  Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane.

Authors:  J W Harbour; W E Smiddy; H W Flynn; P E Rubsamen
Journal:  Am J Ophthalmol       Date:  1996-04       Impact factor: 5.258

10.  Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

Authors:  Jost B Jonas; Ingrid Kreissig; Antje Söfker; Robert F Degenring
Journal:  Arch Ophthalmol       Date:  2003-01
View more
  5 in total

1.  Comparative study of vitrectomy versus intravitreous triamcinolone for diabetic macular edema on randomized paired-eyes.

Authors:  Norihito Doi; Taiji Sakamoto; Yasushi Sonoda; Miho Yasuda; Koji Yonemoto; Noboru Arimura; Eisuke Uchino; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-19       Impact factor: 3.117

Review 2.  Management of diabetic macular edema in Japan: a review and expert opinion.

Authors:  Hiroko Terasaki; Yuichiro Ogura; Shigehiko Kitano; Taiji Sakamoto; Toshinori Murata; Akito Hirakata; Tatsuro Ishibashi
Journal:  Jpn J Ophthalmol       Date:  2017-12-05       Impact factor: 2.447

3.  Effect of vitrectomy on macular microcirculation in patients with diffuse diabetic macular edema.

Authors:  Jung Hyun Park; Se Joon Woo; Youn Jin Ha; Hyeong Gon Yu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-18       Impact factor: 3.117

Review 4.  Physiology of vitreous surgery.

Authors:  Einar Stefánsson
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-11-26       Impact factor: 3.117

5.  Transconjunctival 25-gauge pars plana vitrectomy and internal limiting membrane peeling for chronic macular edema.

Authors:  Minhee Cho; Donald J D'Amico
Journal:  Clin Ophthalmol       Date:  2012-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.